The peptide/hormone telehealth boom is creating a new class of operator — here's what most people get wrong
Everyone sees the demand right now. GLP-1s, peptides, TRT, longevity protocols — patients are searching for this stuff faster than most clinics can onboard providers. But most people trying to enter this space make the same three mistakes:
1. They think "telehealth business" means "website + Stripe link."
It doesn't. You need a compliant provider network, a pharmacy relationship that won't get you shut down, and state-by-state licensing awareness before you take a single payment.
2. They build the brand before the backend.
Slick landing page, zero infrastructure. The operators who last built the boring stuff first — intake flow, provider SOPs, compliant marketing language — then made it pretty.
3. They underestimate how fast this space is professionalizing.
What worked 18 months ago (loose telehealth funnels, vague medical claims) is exactly what regulators are cracking down on now. The winners in this next wave are the ones building it right from day one, not the ones who move fastest.
If you're serious about launching in this space and want the actual playbook — licensing, provider sourcing, tech stack, and patient acquisition that doesn't get flagged — that's what we teach. Worth a look if this is the market you're building in.
